Dolan Daniel P, Swanson Scott J
Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Ann Transl Med. 2021 May;9(10):901. doi: 10.21037/atm.2020.03.143.
The treatment of esophageal cancer has significantly advanced in the last 10 years and now includes multimodal treatment with a continued emphasis on surgical management. Minimally invasive esophagectomy (MIE) has been performed for almost 25 years and, in comparison to open esophagectomy techniques, MIE has shown to be equivalent or better in terms of its perioperative and oncologic outcomes. This paper reviews the evidence for MIE and recommends it should be offered as the first approach for esophagectomy surgery in the modern era.
在过去十年中，食管癌的治疗取得了显著进展，目前包括多模式治疗，且持续强调手术管理。微创食管切除术（MIE）已开展了近25年，与开放食管切除术技术相比，MIE在围手术期和肿瘤学结局方面已显示出相当或更好的效果。本文回顾了支持MIE的证据，并建议在现代应将其作为食管切除术的首选方法。
